PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Bio-Thera Solutions Receives the NMPA’s Approval of BAT1806, a Biosimilar to Actemra

Bio-Thera Solutions Receives the NMPA’s Approval of BAT1806, a Biosimilar to Actemra

January 16, 2023

JP Morgan Special: Dealmaker 2022 – Top M&A Deal of Amgen (Part 02)

JP Morgan Special: Dealmaker 2022 – Top M&A Deal of Amgen (Part 02)

January 16, 2023

Eisai Reports MAA Submission of Leqembi (lecanemab) for Early Alzheimer's Disease in Japan

Eisai Reports MAA Submission of Leqembi (lecanemab) for Early Alzheimer's Disease in Japan

January 16, 2023

Seno Medical Signs an Exclusive Distributor Agreement with Genetik for Imagio Breast Imaging System in Southeast Asia

Seno Medical Signs an Exclusive Distributor Agreement with Genetik for Imagio Breast Imaging System in Southeast Asia

January 16, 2023

Ascletis Reports the Dosing of Four Healthy Patients of ASC11 in Multiple-Dose Escalation P-I Trial for COVID-19

Ascletis Reports the Dosing of Four Healthy Patients of ASC11 in Multiple-Dose Escalation P-I Trial for COVID-19

January 16, 2023

Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder

Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder

January 16, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us